Cargando…
Corrigendum to “Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms” [Mol. Cell. Endocrinol. 440 15 January 2017 57–68]
Autores principales: | Chen, S.C., Brooks, R., Houskeeper, J., Bremner, S.K., Dunlop, J., Viollet, B., Logan, P.J., Salt, I.P., Ahmed, S.F., Yarwood, S.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
North Holland Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854454/ https://www.ncbi.nlm.nih.gov/pubmed/28183460 http://dx.doi.org/10.1016/j.mce.2017.01.049 |
Ejemplares similares
-
Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
por: Chen, Suet Ching, et al.
Publicado: (2017) -
Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150]
por: Nelson, A.W., et al.
Publicado: (2017) -
Inhibition of Adipogenesis by Diphlorethohydroxycarmalol (DPHC) through AMPK Activation in Adipocytes
por: Kang, Min-Cheol, et al.
Publicado: (2019) -
Activation of AMPK for a Break in Hepatic Lipid Accumulation and Circulating Cholesterol
por: Foretz, Marc, et al.
Publicado: (2018) -
Flubendiamide Enhances Adipogenesis and Inhibits AMPKα in 3T3-L1 Adipocytes
por: Sun, Quancai, et al.
Publicado: (2018)